We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$14.9B
AUM Growth
+$734M
(+5.2%)
Cap. Flow
-$271M
Cap. Flow
% of AUM
-1.83%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
304
New
43
Increased
101
Reduced
105
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$215M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Microsoft
MSFT
|
+$163M |
| 4 |
Biogen
BIIB
|
+$147M |
| 5 |
Synchrony
SYF
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$236M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$227M |
| 3 |
AbbVie
ABBV
|
+$169M |
| 4 |
Yum! Brands
YUM
|
+$147M |
| 5 |
Analog Devices
ADI
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.21% |
| 2 | Technology | 15.59% |
| 3 | Consumer Discretionary | 15.51% |
| 4 | Communication Services | 11.55% |
| 5 | Industrials | 11.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Lindblad Expeditions
LIND
$2.21B
| $564K | ﹤0.01% |
50,800
| – | – |
|
252
Berkshire Hathaway Class B
BRK.B
$1.12T
| $556K | ﹤0.01% |
4,213
| – | – |
|
253
IBM
IBM
$223B
| $550K | ﹤0.01% |
4,177
-1,354
| -24% | -$182K |
|
254
SLB Ltd
SLB
$74.8B
| $549K | ﹤0.01% |
7,874
| – | – |
|
255
Procter & Gamble
PG
$338B
| $537K | ﹤0.01% |
6,760
| – | – |
|
|
HA
256
DELISTED
Hawaiian Holdings, Inc.
HA
| $512K | ﹤0.01% |
+14,500
| New | +$501K |
|
257
Medtronic
MDT
$111B
| $475K | ﹤0.01% |
6,178
-98
| -2% | -$7.38K |
|
258
Idexx Laboratories
IDXX
$46.3B
| $467K | ﹤0.01% |
6,400
| – | – |
|
259
Qualcomm
QCOM
$175B
| $452K | ﹤0.01% |
9,042
-114,864
| -93% | -$6.13M |
|
|
OCLR
260
DELISTED
Oclaro Inc.
OCLR
| $442K | ﹤0.01% |
127,100
| – | – |
|
261
Air Products & Chemicals
APD
$67.5B
| $432K | ﹤0.01% |
3,589
| – | – |
|
262
Coca-Cola
KO
$375B
| $430K | ﹤0.01% |
10,000
-210
| -2% | -$8.91K |
|
263
Mueller Water Products
MWA
$4.19B
| $415K | ﹤0.01% |
48,200
| – | – |
|
264
SouthState Bank Corp
SSB
$10.5B
| $410K | ﹤0.01% |
5,700
| – | – |
|
265
PayPal
PYPL
$50.4B
| $409K | ﹤0.01% |
+11,300
| New | +$399K |
|
266
Olin
OLN
$2.14B
| $352K | ﹤0.01% |
+20,400
| New | +$393K |
|
267
Mondelez International
MDLZ
$80B
| $336K | ﹤0.01% |
7,500
+1,500
| +25% | +$67.1K |
|
268
Campbell Soup
CPB
$6.88B
| $315K | ﹤0.01% |
+6,000
| New | +$307K |
|
|
269
Yum! Brands
YUM
$41.2B
| $312K | ﹤0.01% |
5,940
-2,814,114
| -100% | -$147M |
|
270
Boston Properties
BXP
$11.1B
| $281K | ﹤0.01% |
2,200
| – | – |
|
271
Ventas
VTR
$47.6B
| $266K | ﹤0.01% |
4,719
| – | – |
|
272
DexCom
DXCM
$32.1B
| $211K | ﹤0.01% |
+10,300
| New | +$214K |
|
|
273
Analog Devices
ADI
$190B
| – | – |
-2,289,431
| Closed | -$129M |
|
|
AXON
274
Axon Enterprise
AXON
$46.3B
| – | – |
-1,349,858
| Closed | -$29.7M |
|
275
Bloomin' Brands
BLMN
$932M
| – | – |
-1,387,216
| Closed | -$25.2M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Westfield Capital Management held 304 positions worth $14.9B, up 5.2% from $14.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Westfield Capital Management's Q4 2015 filing shows 43 new, 101 increased, 105 reduced and 32 closed positions. Its largest new stake was Alphabet (Google) Class A: 5,804,860 shares worth $226M. The largest sale was Vertex Pharmaceuticals, an estimated $236M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2015 buy was Alphabet (Google) Class A: 5,804,860 shares worth $226M.
- Westfield Capital Management added most to Bristol-Myers Squibb in Q4 2015, an estimated $184M increase.
- Westfield Capital Management's biggest Q4 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $236M.
- Westfield Capital Management fully exited Analog Devices in Q4 2015, selling an estimated $129M.
- Westfield Capital Management's ten largest holdings make up 18% of its $14.9B portfolio in Q4 2015.
- Westfield Capital Management opened 43 new positions and closed 32 in Q4 2015.
- Westfield Capital Management's portfolio value rose 5.2% quarter-over-quarter to $14.9B.
Based on Westfield Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.